Firms
Celgene
- Founded
- —
- Type
- Venture capital
Funds0
No funds on record yet.
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Vividion Therapeutics$82M · 2019-04-30
Nohla Therapeutics$45M · 2018-05-15
Agios$78M · 2011
HiberCell$60M · Unknown date
Vividion$82M · Unknown date
Alexandria Venture Investments
- Vividion Therapeutics$82M · 2019-04-30
- Nohla Therapeutics$45M · 2018-05-15
- Vividion$82M · Unknown date
Casdin Capital
- Vividion Therapeutics$82M · 2019-04-30
- Vividion$82M · Unknown date
Mirae Asset
- Vividion Therapeutics$82M · 2019-04-30
- Vividion$82M · Unknown date
Mubadala Ventures
- Vividion Therapeutics$82M · 2019-04-30
- Vividion$82M · Unknown date
DAG Ventures
Armo BioSciences$67M · 2017-08-29
Decheng Capital
- Armo BioSciences$67M · 2017-08-29
Fidelity Management & Research Company
- Nohla Therapeutics$45M · 2018-05-15
Flagship Ventures
- Agios$78M · 2011
GV- Armo BioSciences$67M · 2017-08-29
Kleiner Perkins
- Armo BioSciences$67M · 2017-08-29
Lightspeed
Agenovir$10M · 2016-05-17
Premier Partners
- Nohla Therapeutics$45M · 2018-05-15
Raptor Group
- HiberCell$60M · Unknown date
Sequoia- Armo BioSciences$67M · 2017-08-29
Third Rock Ventures
- Agios$78M · 2011
Investments
| $82M2019-04-30 | Vividion Therapeutics | ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene |
| $45M2018-05-15 | Nohla Therapeutics | ARCH Venture Partners, Fidelity Management & Research Company, Alexandria Venture Investments, Celgene, Premier Partners |
| $67M2017-08-29 | Armo BioSciences | Sequoia, Kleiner Perkins, DAG Ventures, GV, Celgene, Decheng Capital |
| $10M2016-05-17 | Agenovir | Lightspeed, DCVC, Celgene |
| $78M2011 | Agios | ARCH Venture Partners, Celgene, Third Rock Ventures, Flagship Ventures |
| $60MUnknown date | HiberCell | ARCH Venture Partners, Celgene, Raptor Group |
| $82MUnknown date | Vividion | ARCH Venture Partners, Casdin Capital, Mirae Asset, Alexandria Venture Investments, Mubadala Ventures, Celgene |